The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, ...

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

On August 22, Moderna announced that FDA approved ... On the same day, Pfizer and BioNTech also announced that they received approval for their sBLA for an updated composition of their Omicron ...

The company's vaccine consists of an mRNA sequence encoding a stabilized prefusion F glycoprotein.

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans ...

These vaccines are now available to adults 60 and older. In terms of dosage, the CDC recommends a single dose for individuals over 75.

The Hawaii Department of Health is recommending residents get updated flu and COVID-19 vaccines that are now available.

What about the new COVID booster approved ... that RSV vaccines are not recommended annually like the flu vaccine, and one ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, ...

Updated COVID-19 vaccines are arriving for the fall and winter season. Experts say you should get vaccinated, but you may not ...